Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

NCT00266318 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Interferon Alfacon-1 and Ribavirin

Sponsor

Beth Israel Medical Center

Collaborators

[object Object]